Evidence map›Paper›PMID 23440713›Full record

ArticleLasers in surgery and medicine2013

Microarray analysis of port wine stains before and after pulsed dye laser treatment.

Vivian T Laquer, Peter A Hevezi, Huguette Albrecht, Tina S Chen, Albert Zlotnik, Kristen M Kelly

Open access · bronzeAbstract readControlled Clinical Trial
In one paragraph

Article in Lasers in surgery and medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 7 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 7 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Guideline
  5. Guideline
  6. Japanese clinical practice guidelines for vascular anomalies 2017.Pediatrics international : official journal of the Japan Pediatric Society · 2020
    Guideline
  7. Guideline
  8. Review
  9. Pathogenesis of Port-Wine Stains: Directions for Future Therapies.International journal of molecular sciences · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Laser treatment of port-wine stains.Clinical, cosmetic and investigational dermatology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vivian T LaquerDepartment of Dermatology, University of California, Irvine, Irvine, California, USA. vlaquer@uci.edu
Peter A Hevezi
Huguette Albrecht
Tina S Chen
Albert Zlotnik
Kristen M Kelly
University of California, Irvine · USUniversity of California, Davis · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
WOUND MIGRATION FORCE MONITORINGP41RR001192 · NCRR · UNIVERSITY OF CALIFORNIA-IRVINE · PI LYUBOVITSKY, JULIA · 1985 to 2011
$14.2M
Novel Optical Treatment Approach for Vascular BirthmarksR01HD065536 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHOI, BERNARD, KELLY, KRISTEN M · 2010 to 2014
$1.4M
NCI NIH HHS P30 CA062203NCRR NIH HHS P41 RR001192NCRR NIH HHS RR001192NICHD NIH HHS HD065536NICHD NIH HHS R01 HD065536
6 · The paper itself

Abstract

BACKGROUND AND

objectivesNeither the pathogenesis of port wine stain (PWS) birthmarks nor tissue effects of pulsed dye laser (PDL) treatment of these lesions is fully understood. There are few published reports utilizing gene expression analysis in human PWS skin. We aim to compare gene expression in PWS before and after PDL, using DNA microarrays that represent most, if not all, human genes to obtain comprehensive molecular profiles of PWS lesions and PDL-associated tissue effects. MATERIALS AND

methodsFive human subjects had PDL treatment of their PWS. One week later, three biopsies were taken from each subject: normal skin (N); untreated PWS (PWS); PWS post-PDL (PWS + PDL). Samples included two lower extremity lesions, two facial lesions, and one facial nodule. High-quality total RNA isolated from skin biopsies was processed and applied to Affymetrix Human gene 1.0ST microarrays for gene expression analysis. We performed a 16 pair-wise comparison identifying either up- or down-regulated genes between N versus PWS and PWS versus PWS + PDL for four of the donor samples. The PWS nodule (nPWS) was analyzed separately.

resultsThere was significant variation in gene expression profiles between individuals. By doing pair-wise comparisons between samples taken from the same donor, we were able to identify genes that may participate in the formation of PWS lesions and PDL tissue effects. Genes associated with immune, epidermal, and lipid metabolism were up-regulated in PWS skin. The nPWS exhibited more profound differences in gene expression than the rest of the samples, with significant differential expression of genes associated with angiogenesis, tumorigenesis, and inflammation.

conclusionIn summary, gene expression profiles from N, PWS, and PWS + PDL demonstrated significant variation within samples from the same donor and between donors. By doing pair-wise comparisons between samples taken from the same donor and comparing these results between donors, we were able to identify genes that may participate in formation of PWS and PDL effects. Our preliminary results indicate changes in gene expression of angiogenesis-related genes, suggesting that dysregulation of angiogenic signals and/or components may contribute to PWS pathology.

Indexed as

Down-RegulationGene Expression ProfilingOligonucleotide Array Sequence AnalysisUp-RegulationAdultCluster AnalysisDNAFemaleGenetic MarkersHumansLasers, DyeMaleNeovascularization, PhysiologicPort-Wine StainPrincipal Component AnalysisTreatment OutcomeDNAGenetic Markers

Identifiers

PMID23440713
PMCPMC3930171
OpenAlexW2107262619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.